| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |